JP2023538619A5 - - Google Patents
Info
- Publication number
- JP2023538619A5 JP2023538619A5 JP2023512228A JP2023512228A JP2023538619A5 JP 2023538619 A5 JP2023538619 A5 JP 2023538619A5 JP 2023512228 A JP2023512228 A JP 2023512228A JP 2023512228 A JP2023512228 A JP 2023512228A JP 2023538619 A5 JP2023538619 A5 JP 2023538619A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063067587P | 2020-08-19 | 2020-08-19 | |
| US63/067,587 | 2020-08-19 | ||
| PCT/US2021/046421 WO2022040260A1 (en) | 2020-08-19 | 2021-08-18 | 1h-benzo[d]imidazole derivatives as tlr9 inhibitors for the treatment of fibrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023538619A JP2023538619A (ja) | 2023-09-08 |
| JPWO2022040260A5 JPWO2022040260A5 (https=) | 2024-08-26 |
| JP2023538619A5 true JP2023538619A5 (https=) | 2024-08-26 |
Family
ID=77693625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512228A Pending JP2023538619A (ja) | 2020-08-19 | 2021-08-18 | 線維症の処置のためのｔｌｒ９阻害剤としての１ｈ－ベンゾ［ｄ］イミダゾール誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US12492188B2 (https=) |
| EP (1) | EP4200292B1 (https=) |
| JP (1) | JP2023538619A (https=) |
| KR (1) | KR20230053645A (https=) |
| CN (1) | CN116075510A (https=) |
| AR (1) | AR123286A1 (https=) |
| AU (1) | AU2021329323A1 (https=) |
| BR (1) | BR112023002645A2 (https=) |
| CA (1) | CA3189873A1 (https=) |
| CL (1) | CL2023000440A1 (https=) |
| CO (1) | CO2023001668A2 (https=) |
| ES (1) | ES2999539T3 (https=) |
| IL (1) | IL300702A (https=) |
| MX (1) | MX2023001884A (https=) |
| PE (1) | PE20230843A1 (https=) |
| TW (1) | TW202227409A (https=) |
| WO (1) | WO2022040260A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11807622B2 (en) | 2019-01-30 | 2023-11-07 | Insilico Medicine Ip Limited | TLR 9 inhibitors |
| MX2024009441A (es) * | 2022-02-18 | 2024-08-14 | Bristol Myers Squibb Co | Compuestos de imidazopiridinilo sustituidos utiles como inhibidores del receptor tipo toll 9 (tlr9). |
| US20250163054A1 (en) * | 2022-02-18 | 2025-05-22 | Bristol-Myers Squibb Company | Substituted bicyclic heteroaryl compounds useful as inhibitors of tlr9 |
| CN117466863B (zh) * | 2022-07-20 | 2026-03-24 | 盛睿泽华医药科技（苏州）有限公司 | 含芳香族取代基的苯并咪唑化合物及其制备方法和用途 |
| WO2024102886A1 (en) * | 2022-11-10 | 2024-05-16 | Bristol-Myers Squibb Company | Substituted benzimidazole compounds useful as inhibitors of tlr9 |
| KR20250094727A (ko) * | 2022-11-10 | 2025-06-25 | 브리스톨-마이어스 스큅 컴퍼니 | Tlr9의 억제제로서 유용한 치환된 퀴놀론 화합물 |
| WO2024163380A1 (en) * | 2023-01-31 | 2024-08-08 | Bristol-Myers Squibb Company | Substituted benzimidazole compounds useful as inhibitors of tlr9 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1742637A4 (en) * | 2004-04-23 | 2011-06-08 | Paratek Pharm Innc | TRANSCRIPTION FACTOR MODULATION COMPOUNDS AND METHODS OF USE |
| WO2006113458A1 (en) | 2005-04-15 | 2006-10-26 | Bristol-Myers Squibb Company | Heterocyclic inhibitors of protein arginine methyl transferases |
| GB0602178D0 (en) | 2006-02-03 | 2006-03-15 | Merck Sharp & Dohme | Therapeutic treatment |
| CA2648652A1 (en) | 2006-04-04 | 2007-10-11 | Myriad Genetics, Inc. | Compounds for diseases and disorders |
| US8785489B2 (en) | 2008-10-17 | 2014-07-22 | Boehringer Ingelheim International Gmbh | Heteroaryl substituted indole compounds useful as MMP-13 inhibitors |
| WO2013092467A1 (en) | 2011-12-20 | 2013-06-27 | F. Hoffmann-La Roche Ag | 7-azaindole inhibitors of crac |
| US20130158066A1 (en) | 2011-12-20 | 2013-06-20 | Hoffmann-La Roche Inc. | 4-azaindole inhibitors of crac |
| JP2015515472A (ja) * | 2012-04-06 | 2015-05-28 | ファイザー・インク | ジアシルグリセロールアシルトランスフェラーゼ２阻害薬 |
| WO2013156431A1 (en) | 2012-04-17 | 2013-10-24 | Syngenta Participations Ag | Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives |
| EP2862853B1 (en) | 2012-06-18 | 2020-01-22 | Sumitomo Chemical Co., Ltd | Fused heterocyclic compound |
| EP2738172A1 (en) | 2012-11-28 | 2014-06-04 | Almirall, S.A. | New bicyclic compounds as crac channel modulators |
| CN105992766A (zh) | 2013-12-13 | 2016-10-05 | 武田药品工业株式会社 | 作为tlr抑制剂的吡咯并[3,2-c]吡啶衍生物 |
| AR107032A1 (es) | 2015-12-09 | 2018-03-14 | Padlock Therapeutics Inc | Inhibidores bicíclicos de pad4 |
| US10071079B2 (en) | 2016-06-29 | 2018-09-11 | Bristol-Myers Squibb Company | [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds |
| BR112019001270A2 (pt) | 2016-07-30 | 2019-04-30 | Bristol-Myers Squibb Company | compostos indol substituídos com dimetoxifenila como inibidores de tlr7, tlr8 ou tlr9 |
| JP7028861B2 (ja) | 2016-09-09 | 2022-03-02 | ブリストル－マイヤーズ スクイブ カンパニー | ピリジル置換のインドール化合物 |
| US11370794B2 (en) * | 2016-11-11 | 2022-06-28 | Dynavax Technologies Corporation | Toll-like receptor antagonist compounds and methods of use |
| JP7374772B2 (ja) | 2017-07-05 | 2023-11-07 | シンジェンタ パーティシペーションズ アーゲー | 硫黄含有置換基を有する有害生物防除的に活性な複素環式誘導体 |
| WO2019028302A1 (en) | 2017-08-04 | 2019-02-07 | Bristol-Myers Squibb Company | SUBSTITUTED INDOLE COMPOUNDS USEFUL AS TLR7 / 8/9 INHIBITORS |
| KR102688509B1 (ko) | 2017-08-04 | 2024-07-24 | 브리스톨-마이어스 스큅 컴퍼니 | [1,2,4]트리아졸로[4,3-a]피리디닐 치환된 인돌 화합물 |
| JP7265554B2 (ja) | 2017-11-14 | 2023-04-26 | ブリストル－マイヤーズ スクイブ カンパニー | 置換インドール化合物 |
| KR102781141B1 (ko) | 2017-12-15 | 2025-03-13 | 브리스톨-마이어스 스큅 컴퍼니 | 치환된 인돌 에테르 화합물 |
| EA202091484A1 (ru) | 2017-12-18 | 2021-03-25 | Бристол-Маерс Сквибб Компани | 4-азаиндольные соединения |
| MX2020005462A (es) | 2017-12-19 | 2020-09-07 | Bristol Myers Squibb Co | Compuestos de indol sustituidos utiles como inhibidores de receptores tipo toll (tlr). |
| WO2019126081A1 (en) | 2017-12-19 | 2019-06-27 | Bristol-Myers Squibb Company | Amide substituted indole compounds useful as tlr inhibitors |
| JP7304352B2 (ja) | 2017-12-19 | 2023-07-06 | ブリストル－マイヤーズ スクイブ カンパニー | ６－アザインドール化合物 |
| KR102730859B1 (ko) | 2017-12-20 | 2024-11-15 | 브리스톨-마이어스 스큅 컴퍼니 | 아릴 및 헤테로아릴 치환된 인돌 화합물 |
| EP3728218B1 (en) | 2017-12-20 | 2021-12-01 | Bristol-Myers Squibb Company | Amino indole compounds useful as tlr inhibitors |
| SG11202005733QA (en) | 2017-12-20 | 2020-07-29 | Bristol Myers Squibb Co | Diazaindole compounds |
| WO2019136147A1 (en) * | 2018-01-03 | 2019-07-11 | The Board Of Trustees Of The University Of Illinois | Toll-like receptor signaling inhibitors |
| AU2019319835A1 (en) | 2018-08-08 | 2021-03-25 | Bristol-Myers Squibb Company | Indole and azaindole inhibitors of PAD enzymes |
-
2021
- 2021-08-18 CN CN202180055586.XA patent/CN116075510A/zh active Pending
- 2021-08-18 BR BR112023002645A patent/BR112023002645A2/pt not_active Application Discontinuation
- 2021-08-18 CA CA3189873A patent/CA3189873A1/en active Pending
- 2021-08-18 IL IL300702A patent/IL300702A/en unknown
- 2021-08-18 ES ES21766787T patent/ES2999539T3/es active Active
- 2021-08-18 PE PE2023000281A patent/PE20230843A1/es unknown
- 2021-08-18 KR KR1020237009017A patent/KR20230053645A/ko active Pending
- 2021-08-18 EP EP21766787.2A patent/EP4200292B1/en active Active
- 2021-08-18 TW TW110130430A patent/TW202227409A/zh unknown
- 2021-08-18 JP JP2023512228A patent/JP2023538619A/ja active Pending
- 2021-08-18 US US18/041,719 patent/US12492188B2/en active Active
- 2021-08-18 AR ARP210102330A patent/AR123286A1/es not_active Application Discontinuation
- 2021-08-18 MX MX2023001884A patent/MX2023001884A/es unknown
- 2021-08-18 WO PCT/US2021/046421 patent/WO2022040260A1/en not_active Ceased
- 2021-08-18 AU AU2021329323A patent/AU2021329323A1/en not_active Abandoned
-
2023
- 2023-02-13 CL CL2023000440A patent/CL2023000440A1/es unknown
- 2023-02-15 CO CONC2023/0001668A patent/CO2023001668A2/es unknown